Le Lézard
Classified in: Health, Science and technology
Subjects: SVY, TRI

Feinstein Institute researchers discover how to better record vagus nerve signals


MANHASSET, N.Y., March 15, 2018 /PRNewswire-USNewswire/ -- Feinstein Institute for Medical Research scientists Harold A. Silverman, PhD, Sangeeta S. Chavan, PhD, and their colleagues standardized an experimental protocol to record signals transmitted in the vagus nerve. These findings, published today in Bioelectronic Medicine, are important because the vagus nerve is critical in regulating inflammation. They also expand knowledge in bioelectronic medicine, a nascent field that uses technology to treat disease and injury.

Feinstein Institute scientists are decoding the nervous system

The vagus nerve is a nerve in the neck that connects to every major organ in the body and communicates changes in the body to the brainstem, including infection and inflammation. Signals transmitted in the vagus nerve in an "inflammatory reflex" prevent diseases like sepsis, lupus, hypertension, Crohn's disease, and rheumatoid arthritis. Mapping the signals transmitted in the vagus nerve will help to identify neural pathways regulating these diseases, and develop novel bioelectronic medicine technologies that can be applied to treat disease and injury without the use of pharmaceuticals or experiencing significant side effects.

"We know from our previous studies that electrically stimulating the vagus nerve inhibits immune responses associated with different diseases," said Dr. Chavan, co-corresponding author of the paper, associate professor at the Feinstein Institute and associate professor of molecular medicine at Zucker School of Medicine at Hofstra/Northwell. "In this study, we establish methods to record these signals transmitted in the vagus nerve."

Drs. Silverman, Chavan, and their colleagues, detailed in findings that they developed an electrophysiological recording system to record compound action potentials from the vagus nerve in mice.

"Our new methodology allows us to begin developing ways to decode the nervous system in such a way that we better understand how to detect and regulate inflammation," said Dr. Silverman. "We can use this new understanding to develop devices that simultaneously diagnose and treat disease."

To read the data published in Bioelectronic Medicine, click the following link: https://bioelecmed.biomedcentral.com/articles/10.1186/s42234-018-0002-y. Bioelectronic Medicine is an open-access, international, peer-reviewed journal, which is now disseminated by BioMed Central (BMC), part of Springer Nature. The Feinstein Institute recently partnered with BMC to disseminate Bioelectronic Medicine and Molecular Medicine. Molecular Medicine is an open-access journal that publishes manuscripts containing material relevant to the genetic, molecular, or cellular basis of key physiologic or disease processes. Molecular Medicine also supports the annual Ross Prize in Molecular Medicine with the Feinstein Institute.

"The collaboration with Springer Nature provides a strong platform to effectively publish Bioelectronic Medicine and Molecular Medicine," said Kevin J. Tracey, MD, president and CEO of the Feinstein Institute and editor-in-chief of Bioelectronic Medicine. "The publication of scientific papers is a critical step in spreading knowledge that influences medical and research communities across the globe. It is an early step in the discovery process to help future patients."

About the Feinstein Institute 
The Feinstein Institute for Medical Research is the research arm of Northwell Health, the largest healthcare provider in New York. Home to 50 research laboratories and to clinical research throughout dozens of hospitals and outpatient facilities, the Feinstein Institute includes 4,000 researchers and staff who are making breakthroughs in molecular medicine, genetics, oncology, brain research, mental health, autoimmunity, and bioelectronic medicine ? a new field of science that has the potential to revolutionize medicine. For more information about how we empower imagination and pioneer discovery, visit FeinsteinInstitute.org.

Contact: Emily Ng
516-465-2752
[email protected]

(PRNewsfoto/Northwell Health) (PRNewsfoto/Northwell Health)

SOURCE The Feinstein Institute for Medical Research


These press releases may also interest you

at 00:05
ImmunityBio, Inc. , an immunotherapy company, today announced positive overall survival results in the QUILT 3.055 study of 2nd- and 3rd-line NSCLC patients who progressed after checkpoint inhibitor therapy (pembrolizumab, nivolumab, or atezolizumab)...

at 00:05
The Insurance Institute for Highway Safety is updating its vehicle-to-vehicle front crash prevention test to address crashes that occur at higher speeds and those in which the struck vehicle is a motorcycle or large truck. Only one of the first 10...

at 00:00
Nutriessential.com recently announced its expansion into Oceania, Asia, and the Gulf. The company has been providing science-backed GMP-certified supplements in the US, Europe and Canada since 2005 and decided to expand owing to rising global demands...

24 avr 2024
Summit Clinical Research LLC ("Summit") is deeply saddened by the death of Co-Founder and Chairman Dr. Stephen Harrison. Summit mourns Dr. Harrison and extends its heartfelt condolences to his family and loved ones.   During an illustrious 30-year...

24 avr 2024
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the Drug...

24 avr 2024
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology...



News published on and distributed by: